Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Strategies to Improve RTS,S-4 Uptake and Integration With Other Child Health Services

11 novembre 2026 mis à jour par: Simon Kariuki, Kenya Medical Research Institute

Investigating Approaches to Increase the Uptake of Malaria Vaccine and Other Childhood Health Interventions in Western Kenya: a Feasibility Study

This study will identify and evaluate innovative approaches to leverage malaria vaccine visits as opportunities to enhance the delivery of other child health services in Rarieda sub-county, Siaya County, Kenya where RTS,S became part of their routine childhood immunization programs in 2019. Using a human-centred design approach, the implementation research will be conducted in two phases.

Phase 1 (Diagnose and Design) will consist of formative research to understand current practices, barriers, and facilitators for childhood health and malaria interventions using the WHO's behavioural and social drivers' framework for immunization. Having identified the barriers and facilitators to uptake, the investigators will prioritize drivers and develop innovations for implementation in collaboration with communities, healthcare workers and managers.

Phase 2 (Implement and Evaluate) will focus on implementing and evaluating the innovations developed in Phase 1. Using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) Framework, the study will assess the extent to which the interventions reach the target population, effectiveness of leveraging the malaria vaccine to increase uptake of other child health interventions, the extent of adoption by key stakeholders, and the fidelity and quality of implementation. The investigators will also explore cost and long-term sustainability.

The study will employ a mixed-methods approach, leveraging quantitative and qualitative data from health facility records, surveys, interviews, and observations.

The investigators will generate evidence on leveraging malaria vaccine visits and activities through: (i) innovative implementation strategies designed to maximize immunizations, child health interventions, and malaria prevention uptake; (ii) community engagement as an approach to optimize vaccine uptake and coverage; (iii) detailed qualitative data on the acceptability, perceptions, and barriers to uptake of vaccines and child health interventions; (iv) approaches to ensure access for zero-dose, under-vaccinated and underserved populations.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Réel)

2346

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Siaya, Kenya
        • Ong'ielo Health Centre

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

  1. Primary caregivers of children eligible for malaria vaccination:

    • Inclusion criteria: Primary caregivers (age 18 years or older) of children who are eligible for or have received at least one dose of malaria vaccine
    • Exclusion criteria: Caregivers who are not the primary decision-makers for the child's healthcare or who have resided in the study area for less than 3 months
  2. Healthcare workers involved in immunization services:

    • Inclusion criteria: Clinical officers, nurses, or other healthcare staff directly involved in providing immunization services at the selected health facilities for at least 3 months
    • Exclusion criteria: Healthcare workers not involved in immunization service delivery or who have worked at the facility for less than 3 months
  3. Community health promoters (CHPs):

    • Inclusion criteria: CHPs working in the catchment areas of selected health facilities for at least 6 months
    • Exclusion criteria: CHPs who have not been active in the past 3 months
  4. Community members and leaders:

    • Inclusion criteria: community members and leaders willing to share their views on malaria vaccine barriers and facilitators, and approaches to improve uptake.
    • Exclusion criteria: Community members not willing to participate in the study
  5. Health facility managers and sub-county/county/national health officials:

    • Inclusion criteria: Health facility in-charges, sub-county or county EPI coordinators, and other relevant health officials overseeing immunization services across MoH hierarchy
    • Exclusion criteria: Officials who have been in their current position for less than 3 months

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: ITN - Provision of ITNs at RTS,S-4 visit

Leverage malaria vaccine to improve ITN access and use by providing ITNs at the 4th malaria dose visit, as well as vitamin A, deworming, MR2 and other missing vaccines

- At RTS,S-4 visit, health workers (HW) screen children for missing vaccinations and health services - HW provide catch-up vaccinations and services

Expérimental: CHP - CHP identify and refer under-vaccinated children to health facility

Using malaria vaccine as an entry point, CHPs systematically identified under-vaccinated children during routine household visits and referred them to health facilities (HF), integrating immunization tracking into routine community activities.

  • CHP screen households for under-vaccinated children
  • CHP Provide referral for immunization
  • HW vaccinate referred children
  • HW provide catch-up vaccinations and services
  • CHP follow up on referral completion
Expérimental: SMS - Enhanced defaulter tracing with use of mobile technology

Facility-community linkages were strengthened through CHP engagement and mobile phone-based reminders, including SMS notifications and defaulter tracing

  • HF diaries to record expected children on each date
  • HW record phone contacts in diaries to remind caregivers about visits (SMS or calls)
  • If caregivers cannot be reached, HW share contacts by SMS/WhatsApp with CHPs to trace defaulters at the house and provide referrals
  • HW screen & provide catch-up vaccinations & services
Expérimental: SS - Strengthening immunization systems, health services, and interdepartmental collaboration

Multi-component intervention: 1) strengthening immunizations and health services through interdepartmental collaboration; 2) improving vaccine visit awareness, preparedness, and defaulter tracing; and 3) targeted monthly community outreaches, with CHPs mobilizing caregivers of children due or overdue for vaccination.

  • Screening children for vaccination status at triage
  • HW use colored ink to better visualize return dates in home-based records
  • HW Screen & provide catch-up vaccinations & services
  • CHPs trace defaulters, provide & follow up on referrals
  • HF diaries to record expected children on each date
  • HF conduct targeted community outreaches
  • CHP mobilize defaulters for scheduled outreaches

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Reach
Délai: Three months

Vaccine coverage (%) in target populations and characteristics of vaccinated populations reached through study interventions

Three months
Effectiveness
Délai: Three months

Percentage increase in primary (dose 1-3) and booster (4th) doses post-interventions in age-eligible children

Three months
Adoption
Délai: Three months

Proportion of RTS,S vaccines provided concurrently with other vaccines/services.

Three months
Implementation
Délai: Three months

Perceived feasibility of interventions by health workers, caregivers, and community. A semi-structured interview guide will be used to assess implementation experiences.

Three months
Maintenance
Délai: Three months

Drivers of maintenance of interventions. A semi-structured interview guide will be used to elicit what it would take to continue implementing interventions beyond the study period.

Three months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Simon Kariuki, PhD, Kenya Medical Research Institute
  • Chercheur principal: Nelli Westercamp, PhD, Centres for Disease Control and Prevention

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 juillet 2025

Achèvement primaire (Réel)

4 décembre 2025

Achèvement de l'étude (Réel)

4 décembre 2025

Dates d'inscription aux études

Première soumission

22 octobre 2026

Première soumission répondant aux critères de contrôle qualité

11 novembre 2026

Première publication (Réel)

17 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

17 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

11 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Only aggregated data is required for reports and manuscripts.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner